nodes	percent_of_prediction	percent_of_DWPC	metapath
Daunorubicin—Topoisomerase Inhibitors—Topotecan—cervical cancer	0.824	1	CiPCiCtD
Daunorubicin—ABCG2—Topotecan—cervical cancer	0.0759	0.634	CbGbCtD
Daunorubicin—ABCB1—Topotecan—cervical cancer	0.0274	0.229	CbGbCtD
Daunorubicin—CYP3A4—Topotecan—cervical cancer	0.0164	0.137	CbGbCtD
Daunorubicin—TOP2A—Irinotecan—Topotecan—cervical cancer	0.00134	1	CbGdCrCtD
Daunorubicin—Myelosuppression—Topotecan—cervical cancer	0.00112	0.0815	CcSEcCtD
Daunorubicin—Mucosal inflammation—Topotecan—cervical cancer	0.000947	0.069	CcSEcCtD
Daunorubicin—Febrile neutropenia—Topotecan—cervical cancer	0.000872	0.0635	CcSEcCtD
Daunorubicin—NR5A1—female reproductive system—cervical cancer	0.00081	0.0217	CbGeAlD
Daunorubicin—NR5A1—female gonad—cervical cancer	0.000737	0.0198	CbGeAlD
Daunorubicin—YWHAG—uterine cervix—cervical cancer	0.000714	0.0191	CbGeAlD
Daunorubicin—ABCC6—renal system—cervical cancer	0.00071	0.019	CbGeAlD
Daunorubicin—XDH—uterine cervix—cervical cancer	0.000697	0.0187	CbGeAlD
Daunorubicin—TOP2B—uterine cervix—cervical cancer	0.000688	0.0184	CbGeAlD
Daunorubicin—YWHAG—decidua—cervical cancer	0.000681	0.0182	CbGeAlD
Daunorubicin—YWHAG—renal system—cervical cancer	0.000668	0.0179	CbGeAlD
Daunorubicin—TOP2B—decidua—cervical cancer	0.000656	0.0176	CbGeAlD
Daunorubicin—XDH—renal system—cervical cancer	0.000652	0.0175	CbGeAlD
Daunorubicin—YWHAG—endometrium—cervical cancer	0.000646	0.0173	CbGeAlD
Daunorubicin—TOP2B—renal system—cervical cancer	0.000644	0.0173	CbGeAlD
Daunorubicin—Rigors—Topotecan—cervical cancer	0.000642	0.0468	CcSEcCtD
Daunorubicin—XDH—endometrium—cervical cancer	0.00063	0.0169	CbGeAlD
Daunorubicin—YWHAG—mammalian vulva—cervical cancer	0.000625	0.0167	CbGeAlD
Daunorubicin—TOP2B—endometrium—cervical cancer	0.000623	0.0167	CbGeAlD
Daunorubicin—XDH—mammalian vulva—cervical cancer	0.00061	0.0163	CbGeAlD
Daunorubicin—TOP2B—mammalian vulva—cervical cancer	0.000602	0.0161	CbGeAlD
Daunorubicin—Extravasation—Topotecan—cervical cancer	0.000601	0.0438	CcSEcCtD
Daunorubicin—YWHAG—uterus—cervical cancer	0.000595	0.016	CbGeAlD
Daunorubicin—TOP2B—uterus—cervical cancer	0.000574	0.0154	CbGeAlD
Daunorubicin—POR—uterine cervix—cervical cancer	0.000543	0.0146	CbGeAlD
Daunorubicin—YWHAG—female reproductive system—cervical cancer	0.000535	0.0143	CbGeAlD
Daunorubicin—XDH—female reproductive system—cervical cancer	0.000522	0.014	CbGeAlD
Daunorubicin—POR—decidua—cervical cancer	0.000518	0.0139	CbGeAlD
Daunorubicin—TOP2B—female reproductive system—cervical cancer	0.000516	0.0138	CbGeAlD
Daunorubicin—SLC22A2—renal system—cervical cancer	0.000511	0.0137	CbGeAlD
Daunorubicin—TOP2A—uterine cervix—cervical cancer	0.000506	0.0136	CbGeAlD
Daunorubicin—Neuropathy—Topotecan—cervical cancer	0.000492	0.0359	CcSEcCtD
Daunorubicin—POR—endometrium—cervical cancer	0.000491	0.0132	CbGeAlD
Daunorubicin—YWHAG—female gonad—cervical cancer	0.000487	0.0131	CbGeAlD
Daunorubicin—YWHAG—vagina—cervical cancer	0.000484	0.013	CbGeAlD
Daunorubicin—TOP2A—decidua—cervical cancer	0.000482	0.0129	CbGeAlD
Daunorubicin—POR—mammalian vulva—cervical cancer	0.000475	0.0127	CbGeAlD
Daunorubicin—XDH—vagina—cervical cancer	0.000472	0.0127	CbGeAlD
Daunorubicin—TOP2B—female gonad—cervical cancer	0.000469	0.0126	CbGeAlD
Daunorubicin—TOP2B—vagina—cervical cancer	0.000467	0.0125	CbGeAlD
Daunorubicin—TOP2A—endometrium—cervical cancer	0.000458	0.0123	CbGeAlD
Daunorubicin—Ear pain—Topotecan—cervical cancer	0.000446	0.0325	CcSEcCtD
Daunorubicin—TOP2A—mammalian vulva—cervical cancer	0.000443	0.0119	CbGeAlD
Daunorubicin—ABCC10—uterine cervix—cervical cancer	0.000431	0.0115	CbGeAlD
Daunorubicin—TOP2A—uterus—cervical cancer	0.000422	0.0113	CbGeAlD
Daunorubicin—ABCC10—decidua—cervical cancer	0.000411	0.011	CbGeAlD
Daunorubicin—ABCC10—renal system—cervical cancer	0.000403	0.0108	CbGeAlD
Daunorubicin—Anaphylactoid reaction—Topotecan—cervical cancer	0.000393	0.0287	CcSEcCtD
Daunorubicin—ABCC10—endometrium—cervical cancer	0.00039	0.0104	CbGeAlD
Daunorubicin—ABCC10—mammalian vulva—cervical cancer	0.000377	0.0101	CbGeAlD
Daunorubicin—POR—female gonad—cervical cancer	0.00037	0.00992	CbGeAlD
Daunorubicin—POR—vagina—cervical cancer	0.000368	0.00986	CbGeAlD
Daunorubicin—Cardiac arrest—Topotecan—cervical cancer	0.000362	0.0264	CcSEcCtD
Daunorubicin—ABCC10—uterus—cervical cancer	0.000359	0.00963	CbGeAlD
Daunorubicin—NR5A1—Nuclear Receptors—RARB—cervical cancer	0.000352	0.088	CbGpPWpGaD
Daunorubicin—TOP2A—female gonad—cervical cancer	0.000345	0.00925	CbGeAlD
Daunorubicin—TOP2A—vagina—cervical cancer	0.000343	0.00919	CbGeAlD
Daunorubicin—ABCC2—renal system—cervical cancer	0.000324	0.00868	CbGeAlD
Daunorubicin—ABCC10—female reproductive system—cervical cancer	0.000323	0.00865	CbGeAlD
Daunorubicin—CYP1B1—decidua—cervical cancer	0.000323	0.00865	CbGeAlD
Daunorubicin—CYP1B1—renal system—cervical cancer	0.000317	0.0085	CbGeAlD
Daunorubicin—YWHAG—lymph node—cervical cancer	0.000313	0.00839	CbGeAlD
Daunorubicin—Pancytopenia—Topotecan—cervical cancer	0.000312	0.0228	CcSEcCtD
Daunorubicin—Neutropenia—Topotecan—cervical cancer	0.000308	0.0224	CcSEcCtD
Daunorubicin—ABCC1—uterine cervix—cervical cancer	0.000305	0.00817	CbGeAlD
Daunorubicin—TOP2B—lymph node—cervical cancer	0.000302	0.00809	CbGeAlD
Daunorubicin—ABCC10—female gonad—cervical cancer	0.000294	0.00787	CbGeAlD
Daunorubicin—ABCC10—vagina—cervical cancer	0.000292	0.00783	CbGeAlD
Daunorubicin—ABCC1—decidua—cervical cancer	0.00029	0.00778	CbGeAlD
Daunorubicin—Neuropathy peripheral—Topotecan—cervical cancer	0.000288	0.021	CcSEcCtD
Daunorubicin—Stomatitis—Topotecan—cervical cancer	0.000286	0.0208	CcSEcCtD
Daunorubicin—CYP1B1—uterus—cervical cancer	0.000282	0.00757	CbGeAlD
Daunorubicin—NR5A1—Nuclear Receptor transcription pathway—RARB—cervical cancer	0.000278	0.0695	CbGpPWpGaD
Daunorubicin—ABCC1—endometrium—cervical cancer	0.000276	0.00739	CbGeAlD
Daunorubicin—ABCC1—mammalian vulva—cervical cancer	0.000267	0.00715	CbGeAlD
Daunorubicin—Rhinitis—Topotecan—cervical cancer	0.000264	0.0192	CcSEcCtD
Daunorubicin—ABCC2—female reproductive system—cervical cancer	0.000259	0.00695	CbGeAlD
Daunorubicin—ABCC1—uterus—cervical cancer	0.000254	0.00681	CbGeAlD
Daunorubicin—CYP1B1—female reproductive system—cervical cancer	0.000254	0.0068	CbGeAlD
Daunorubicin—ABCG2—uterine cervix—cervical cancer	0.000252	0.00676	CbGeAlD
Daunorubicin—CYP1A1—epithelium—cervical cancer	0.000242	0.00648	CbGeAlD
Daunorubicin—ABCG2—decidua—cervical cancer	0.00024	0.00644	CbGeAlD
Daunorubicin—CYP1A1—uterine cervix—cervical cancer	0.00024	0.00642	CbGeAlD
Daunorubicin—POR—lymph node—cervical cancer	0.000238	0.00638	CbGeAlD
Daunorubicin—Chills—Topotecan—cervical cancer	0.000236	0.0172	CcSEcCtD
Daunorubicin—CYP3A5—uterine cervix—cervical cancer	0.000234	0.00628	CbGeAlD
Daunorubicin—Alopecia—Topotecan—cervical cancer	0.000233	0.017	CcSEcCtD
Daunorubicin—CYP1B1—female gonad—cervical cancer	0.000231	0.00619	CbGeAlD
Daunorubicin—ABCG2—endometrium—cervical cancer	0.000228	0.00612	CbGeAlD
Daunorubicin—CYP1A2—renal system—cervical cancer	0.000227	0.00609	CbGeAlD
Daunorubicin—CYP1A1—renal system—cervical cancer	0.000224	0.00601	CbGeAlD
Daunorubicin—TOP2A—lymph node—cervical cancer	0.000222	0.00595	CbGeAlD
Daunorubicin—Back pain—Topotecan—cervical cancer	0.000222	0.0162	CcSEcCtD
Daunorubicin—ABCG2—mammalian vulva—cervical cancer	0.000221	0.00592	CbGeAlD
Daunorubicin—CYP3A5—renal system—cervical cancer	0.000219	0.00587	CbGeAlD
Daunorubicin—Ill-defined disorder—Topotecan—cervical cancer	0.000213	0.0155	CcSEcCtD
Daunorubicin—Anaemia—Topotecan—cervical cancer	0.000212	0.0154	CcSEcCtD
Daunorubicin—ABCG2—uterus—cervical cancer	0.00021	0.00564	CbGeAlD
Daunorubicin—CYP1A1—mammalian vulva—cervical cancer	0.00021	0.00562	CbGeAlD
Daunorubicin—ABCC1—female gonad—cervical cancer	0.000208	0.00557	CbGeAlD
Daunorubicin—Malaise—Topotecan—cervical cancer	0.000207	0.0151	CcSEcCtD
Daunorubicin—ABCC1—vagina—cervical cancer	0.000207	0.00554	CbGeAlD
Daunorubicin—Leukopenia—Topotecan—cervical cancer	0.000205	0.015	CcSEcCtD
Daunorubicin—YWHAG—mTOR signaling pathway—YY1—cervical cancer	0.000202	0.0504	CbGpPWpGaD
Daunorubicin—Cough—Topotecan—cervical cancer	0.0002	0.0146	CcSEcCtD
Daunorubicin—CYP1A1—uterus—cervical cancer	0.0002	0.00535	CbGeAlD
Daunorubicin—Myalgia—Topotecan—cervical cancer	0.000195	0.0142	CcSEcCtD
Daunorubicin—Arthralgia—Topotecan—cervical cancer	0.000195	0.0142	CcSEcCtD
Daunorubicin—Chest pain—Topotecan—cervical cancer	0.000195	0.0142	CcSEcCtD
Daunorubicin—Discomfort—Topotecan—cervical cancer	0.000193	0.014	CcSEcCtD
Daunorubicin—ABCC10—lymph node—cervical cancer	0.000189	0.00506	CbGeAlD
Daunorubicin—Anaphylactic shock—Topotecan—cervical cancer	0.000187	0.0136	CcSEcCtD
Daunorubicin—Infection—Topotecan—cervical cancer	0.000186	0.0135	CcSEcCtD
Daunorubicin—Thrombocytopenia—Topotecan—cervical cancer	0.000183	0.0133	CcSEcCtD
Daunorubicin—Hyperhidrosis—Topotecan—cervical cancer	0.000181	0.0132	CcSEcCtD
Daunorubicin—CYP1A1—female reproductive system—cervical cancer	0.00018	0.00481	CbGeAlD
Daunorubicin—Anorexia—Topotecan—cervical cancer	0.000178	0.013	CcSEcCtD
Daunorubicin—ABCG2—female gonad—cervical cancer	0.000172	0.00461	CbGeAlD
Daunorubicin—ABCG2—vagina—cervical cancer	0.000171	0.00458	CbGeAlD
Daunorubicin—Musculoskeletal discomfort—Topotecan—cervical cancer	0.00017	0.0124	CcSEcCtD
Daunorubicin—Dyspnoea—Topotecan—cervical cancer	0.000167	0.0122	CcSEcCtD
Daunorubicin—CYP3A4—renal system—cervical cancer	0.000164	0.00441	CbGeAlD
Daunorubicin—CYP1A1—female gonad—cervical cancer	0.000163	0.00438	CbGeAlD
Daunorubicin—Decreased appetite—Topotecan—cervical cancer	0.000163	0.0118	CcSEcCtD
Daunorubicin—CYP1A1—vagina—cervical cancer	0.000162	0.00435	CbGeAlD
Daunorubicin—Fatigue—Topotecan—cervical cancer	0.000161	0.0118	CcSEcCtD
Daunorubicin—Constipation—Topotecan—cervical cancer	0.00016	0.0117	CcSEcCtD
Daunorubicin—Pain—Topotecan—cervical cancer	0.00016	0.0117	CcSEcCtD
Daunorubicin—CYP3A5—female gonad—cervical cancer	0.00016	0.00428	CbGeAlD
Daunorubicin—CYP3A5—vagina—cervical cancer	0.000159	0.00425	CbGeAlD
Daunorubicin—Feeling abnormal—Topotecan—cervical cancer	0.000154	0.0112	CcSEcCtD
Daunorubicin—Gastrointestinal pain—Topotecan—cervical cancer	0.000153	0.0111	CcSEcCtD
Daunorubicin—ABCC2—lymph node—cervical cancer	0.000152	0.00406	CbGeAlD
Daunorubicin—Urticaria—Topotecan—cervical cancer	0.000149	0.0108	CcSEcCtD
Daunorubicin—CYP1B1—lymph node—cervical cancer	0.000149	0.00398	CbGeAlD
Daunorubicin—Abdominal pain—Topotecan—cervical cancer	0.000148	0.0108	CcSEcCtD
Daunorubicin—Body temperature increased—Topotecan—cervical cancer	0.000148	0.0108	CcSEcCtD
Daunorubicin—ABCB11—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—cervical cancer	0.000139	0.0346	CbGpPWpGaD
Daunorubicin—Hypersensitivity—Topotecan—cervical cancer	0.000138	0.01	CcSEcCtD
Daunorubicin—NR5A1—Transcriptional regulation of pluripotent stem cells—STAT3—cervical cancer	0.000134	0.0336	CbGpPWpGaD
Daunorubicin—Asthenia—Topotecan—cervical cancer	0.000134	0.00978	CcSEcCtD
Daunorubicin—NR5A1—Developmental Biology—INSM1—cervical cancer	0.000134	0.0334	CbGpPWpGaD
Daunorubicin—ABCC1—lymph node—cervical cancer	0.000134	0.00358	CbGeAlD
Daunorubicin—Pruritus—Topotecan—cervical cancer	0.000132	0.00964	CcSEcCtD
Daunorubicin—CYP3A4—female reproductive system—cervical cancer	0.000132	0.00353	CbGeAlD
Daunorubicin—Diarrhoea—Topotecan—cervical cancer	0.000128	0.00933	CcSEcCtD
Daunorubicin—ABCB1—epithelium—cervical cancer	0.000126	0.00336	CbGeAlD
Daunorubicin—ABCB1—uterine cervix—cervical cancer	0.000124	0.00333	CbGeAlD
Daunorubicin—Dizziness—Topotecan—cervical cancer	0.000124	0.00901	CcSEcCtD
Daunorubicin—Vomiting—Topotecan—cervical cancer	0.000119	0.00867	CcSEcCtD
Daunorubicin—ABCB1—decidua—cervical cancer	0.000119	0.00318	CbGeAlD
Daunorubicin—Rash—Topotecan—cervical cancer	0.000118	0.00859	CcSEcCtD
Daunorubicin—Dermatitis—Topotecan—cervical cancer	0.000118	0.00859	CcSEcCtD
Daunorubicin—Headache—Topotecan—cervical cancer	0.000117	0.00854	CcSEcCtD
Daunorubicin—ABCB1—renal system—cervical cancer	0.000116	0.00312	CbGeAlD
Daunorubicin—ABCB1—endometrium—cervical cancer	0.000113	0.00302	CbGeAlD
Daunorubicin—Nausea—Topotecan—cervical cancer	0.000111	0.0081	CcSEcCtD
Daunorubicin—ABCG2—lymph node—cervical cancer	0.000111	0.00296	CbGeAlD
Daunorubicin—ABCB1—mammalian vulva—cervical cancer	0.000109	0.00292	CbGeAlD
Daunorubicin—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—cervical cancer	0.000105	0.0263	CbGpPWpGaD
Daunorubicin—CYP1A1—lymph node—cervical cancer	0.000105	0.00281	CbGeAlD
Daunorubicin—ABCB1—uterus—cervical cancer	0.000104	0.00278	CbGeAlD
Daunorubicin—CYP1B1—Tryptophan metabolism—UBE3A—cervical cancer	9.7e-05	0.0242	CbGpPWpGaD
Daunorubicin—ABCB1—female reproductive system—cervical cancer	9.32e-05	0.0025	CbGeAlD
Daunorubicin—ABCB1—female gonad—cervical cancer	8.48e-05	0.00227	CbGeAlD
Daunorubicin—ABCB1—vagina—cervical cancer	8.43e-05	0.00226	CbGeAlD
Daunorubicin—YWHAG—Intrinsic Pathway for Apoptosis—CASP8—cervical cancer	7.35e-05	0.0184	CbGpPWpGaD
Daunorubicin—TOP2A—Gastric Cancer Network 1—NOTCH1—cervical cancer	7.01e-05	0.0175	CbGpPWpGaD
Daunorubicin—YWHAG—Class I PI3K signaling events mediated by Akt—MTOR—cervical cancer	6.46e-05	0.0161	CbGpPWpGaD
Daunorubicin—ABCG2—Fluoropyrimidine Activity—SMUG1—cervical cancer	6.4e-05	0.016	CbGpPWpGaD
Daunorubicin—ABCG2—HIF-1-alpha transcription factor network—CA9—cervical cancer	6.34e-05	0.0158	CbGpPWpGaD
Daunorubicin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—HES1—cervical cancer	6.31e-05	0.0158	CbGpPWpGaD
Daunorubicin—CYP1A1—Tryptophan metabolism—UBE3A—cervical cancer	5.98e-05	0.0149	CbGpPWpGaD
Daunorubicin—YWHAG—Intrinsic Pathway for Apoptosis—CASP3—cervical cancer	5.56e-05	0.0139	CbGpPWpGaD
Daunorubicin—YWHAG—LKB1 signaling events—MTOR—cervical cancer	5.48e-05	0.0137	CbGpPWpGaD
Daunorubicin—ABCB1—lymph node—cervical cancer	5.45e-05	0.00146	CbGeAlD
Daunorubicin—YWHAG—Regulation of nuclear beta catenin signaling and target gene transcription—TERT—cervical cancer	5.16e-05	0.0129	CbGpPWpGaD
Daunorubicin—CYP1B1—Estrogen Receptor Pathway—STAT3—cervical cancer	5.16e-05	0.0129	CbGpPWpGaD
Daunorubicin—YWHAG—Activation of BH3-only proteins—TP53—cervical cancer	4.99e-05	0.0125	CbGpPWpGaD
Daunorubicin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—cervical cancer	4.95e-05	0.0124	CbGpPWpGaD
Daunorubicin—NR5A1—Generic Transcription Pathway—RARB—cervical cancer	4.81e-05	0.012	CbGpPWpGaD
Daunorubicin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—NOTCH1—cervical cancer	4.76e-05	0.0119	CbGpPWpGaD
Daunorubicin—ABCG2—Fluoropyrimidine Activity—MTHFR—cervical cancer	4.48e-05	0.0112	CbGpPWpGaD
Daunorubicin—TOP2A—Circadian rythm related genes—UBE3A—cervical cancer	4.45e-05	0.0111	CbGpPWpGaD
Daunorubicin—TOP2A—Gastric Cancer Network 2—CTNNB1—cervical cancer	4.41e-05	0.011	CbGpPWpGaD
Daunorubicin—YWHAG—FoxO family signaling—CTNNB1—cervical cancer	4.37e-05	0.0109	CbGpPWpGaD
Daunorubicin—CYP1B1—Aryl Hydrocarbon Receptor Pathway—HES1—cervical cancer	4.3e-05	0.0107	CbGpPWpGaD
Daunorubicin—YWHAG—Role of Calcineurin-dependent NFAT signaling in lymphocytes—CASP3—cervical cancer	4.2e-05	0.0105	CbGpPWpGaD
Daunorubicin—XDH—Selenium Micronutrient Network—MTHFR—cervical cancer	4.19e-05	0.0105	CbGpPWpGaD
Daunorubicin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—cervical cancer	3.96e-05	0.00988	CbGpPWpGaD
Daunorubicin—YWHAG—mTOR signaling pathway—MTOR—cervical cancer	3.89e-05	0.00971	CbGpPWpGaD
Daunorubicin—CYP1A2—Tryptophan metabolism—UBE3A—cervical cancer	3.81e-05	0.00952	CbGpPWpGaD
Daunorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—RARB—cervical cancer	3.78e-05	0.00945	CbGpPWpGaD
Daunorubicin—YWHAG—a6b1 and a6b4 Integrin signaling—EGFR—cervical cancer	3.71e-05	0.00927	CbGpPWpGaD
Daunorubicin—YWHAG—Intrinsic Pathway for Apoptosis—TP53—cervical cancer	3.57e-05	0.00891	CbGpPWpGaD
Daunorubicin—TOP2A—Gastric Cancer Network 2—EGFR—cervical cancer	3.5e-05	0.00873	CbGpPWpGaD
Daunorubicin—YWHAG—SIDS Susceptibility Pathways—HES1—cervical cancer	3.45e-05	0.00863	CbGpPWpGaD
Daunorubicin—ABCB1—HIF-1-alpha transcription factor network—CA9—cervical cancer	3.43e-05	0.00856	CbGpPWpGaD
Daunorubicin—YWHAG—LKB1 signaling events—TP53—cervical cancer	3.23e-05	0.00807	CbGpPWpGaD
Daunorubicin—NR5A1—Generic Transcription Pathway—NOTCH2—cervical cancer	3.19e-05	0.00796	CbGpPWpGaD
Daunorubicin—CYP1A1—Estrogen Receptor Pathway—STAT3—cervical cancer	3.18e-05	0.00794	CbGpPWpGaD
Daunorubicin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—cervical cancer	3.05e-05	0.00762	CbGpPWpGaD
Daunorubicin—YWHAG—Regulation of nuclear beta catenin signaling and target gene transcription—CTNNB1—cervical cancer	2.96e-05	0.00738	CbGpPWpGaD
Daunorubicin—CYP3A4—Tryptophan metabolism—UBE3A—cervical cancer	2.94e-05	0.00734	CbGpPWpGaD
Daunorubicin—TOP2A—Gastric Cancer Network 2—TP53—cervical cancer	2.94e-05	0.00733	CbGpPWpGaD
Daunorubicin—YWHAG—ErbB1 downstream signaling—MTOR—cervical cancer	2.68e-05	0.0067	CbGpPWpGaD
Daunorubicin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—HES1—cervical cancer	2.65e-05	0.00661	CbGpPWpGaD
Daunorubicin—ABCG2—HIF-1-alpha transcription factor network—TERT—cervical cancer	2.57e-05	0.00641	CbGpPWpGaD
Daunorubicin—NR5A1—Developmental Biology—HES1—cervical cancer	2.46e-05	0.00614	CbGpPWpGaD
Daunorubicin—YWHAG—Apoptosis—CASP8—cervical cancer	2.39e-05	0.00596	CbGpPWpGaD
Daunorubicin—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—cervical cancer	2.34e-05	0.00585	CbGpPWpGaD
Daunorubicin—NR5A1—Gene Expression—RARB—cervical cancer	2.32e-05	0.00578	CbGpPWpGaD
Daunorubicin—YWHAG—ErbB1 downstream signaling—STAT3—cervical cancer	2.07e-05	0.00518	CbGpPWpGaD
Daunorubicin—CYP1A2—Estrogen Receptor Pathway—STAT3—cervical cancer	2.03e-05	0.00506	CbGpPWpGaD
Daunorubicin—NR5A1—Generic Transcription Pathway—NOTCH1—cervical cancer	1.97e-05	0.00492	CbGpPWpGaD
Daunorubicin—YWHAG—ErbB1 downstream signaling—EGFR—cervical cancer	1.88e-05	0.00471	CbGpPWpGaD
Daunorubicin—NR5A1—Developmental Biology—NOTCH1—cervical cancer	1.86e-05	0.00464	CbGpPWpGaD
Daunorubicin—ABCB1—Allograft Rejection—HLA-DPB1—cervical cancer	1.85e-05	0.00462	CbGpPWpGaD
Daunorubicin—YWHAG—Apoptosis—CASP3—cervical cancer	1.81e-05	0.00451	CbGpPWpGaD
Daunorubicin—YWHAG—PDGFR-beta signaling pathway—STAT3—cervical cancer	1.8e-05	0.0045	CbGpPWpGaD
Daunorubicin—YWHAG—SIDS Susceptibility Pathways—CASP3—cervical cancer	1.8e-05	0.00449	CbGpPWpGaD
Daunorubicin—YWHAG—Apoptosis—CTNNB1—cervical cancer	1.74e-05	0.00435	CbGpPWpGaD
Daunorubicin—YWHAG—SIDS Susceptibility Pathways—CTNNB1—cervical cancer	1.73e-05	0.00433	CbGpPWpGaD
Daunorubicin—CYP1B1—Aryl Hydrocarbon Receptor—EGFR—cervical cancer	1.71e-05	0.00426	CbGpPWpGaD
Daunorubicin—CYP1B1—Aryl Hydrocarbon Receptor Pathway—EGFR—cervical cancer	1.71e-05	0.00426	CbGpPWpGaD
Daunorubicin—ABCG2—Fluoropyrimidine Activity—TP53—cervical cancer	1.7e-05	0.00425	CbGpPWpGaD
Daunorubicin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—HES1—cervical cancer	1.69e-05	0.00421	CbGpPWpGaD
Daunorubicin—YWHAG—Cell Cycle—TP53—cervical cancer	1.62e-05	0.00404	CbGpPWpGaD
Daunorubicin—NR5A1—Gene Expression—NOTCH2—cervical cancer	1.53e-05	0.00383	CbGpPWpGaD
Daunorubicin—ABCB1—Allograft Rejection—HLA-DQB1—cervical cancer	1.44e-05	0.00361	CbGpPWpGaD
Daunorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—CASP8—cervical cancer	1.41e-05	0.00353	CbGpPWpGaD
Daunorubicin—ABCB1—HIF-1-alpha transcription factor network—TERT—cervical cancer	1.39e-05	0.00346	CbGpPWpGaD
Daunorubicin—TOP2A—Retinoblastoma (RB) in Cancer—TP53—cervical cancer	1.29e-05	0.00321	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—RARB—cervical cancer	1.25e-05	0.00311	CbGpPWpGaD
Daunorubicin—NR5A1—Developmental Biology—CTNNB1—cervical cancer	1.23e-05	0.00308	CbGpPWpGaD
Daunorubicin—YWHAG—Apoptosis—TP53—cervical cancer	1.16e-05	0.00289	CbGpPWpGaD
Daunorubicin—YWHAG—Cell Cycle—TERT—cervical cancer	1.11e-05	0.00278	CbGpPWpGaD
Daunorubicin—NR5A1—Developmental Biology—STAT3—cervical cancer	1.07e-05	0.00268	CbGpPWpGaD
Daunorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—CASP3—cervical cancer	1.07e-05	0.00267	CbGpPWpGaD
Daunorubicin—CYP1A1—Aryl Hydrocarbon Receptor—EGFR—cervical cancer	1.05e-05	0.00263	CbGpPWpGaD
Daunorubicin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—cervical cancer	1.05e-05	0.00263	CbGpPWpGaD
Daunorubicin—XDH—Metabolism—CA9—cervical cancer	1.03e-05	0.00258	CbGpPWpGaD
Daunorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—CTNNB1—cervical cancer	1.03e-05	0.00257	CbGpPWpGaD
Daunorubicin—NR5A1—Developmental Biology—EGFR—cervical cancer	9.77e-06	0.00244	CbGpPWpGaD
Daunorubicin—NR5A1—Gene Expression—NOTCH1—cervical cancer	9.49e-06	0.00237	CbGpPWpGaD
Daunorubicin—ABCB1—Allograft Rejection—CASP8—cervical cancer	9.43e-06	0.00235	CbGpPWpGaD
Daunorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—EGFR—cervical cancer	8.16e-06	0.00204	CbGpPWpGaD
Daunorubicin—TOP2A—Cell Cycle—TERT—cervical cancer	7.79e-06	0.00195	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—CA9—cervical cancer	7.62e-06	0.0019	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—WNT2—cervical cancer	7.24e-06	0.00181	CbGpPWpGaD
Daunorubicin—ABCB1—Allograft Rejection—CASP3—cervical cancer	7.13e-06	0.00178	CbGpPWpGaD
Daunorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—cervical cancer	6.85e-06	0.00171	CbGpPWpGaD
Daunorubicin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—cervical cancer	6.7e-06	0.00167	CbGpPWpGaD
Daunorubicin—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—cervical cancer	6.7e-06	0.00167	CbGpPWpGaD
Daunorubicin—TOP2A—Circadian rythm related genes—TP53—cervical cancer	6.58e-06	0.00164	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—CA9—cervical cancer	5.73e-06	0.00143	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—CA9—cervical cancer	5.54e-06	0.00138	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—WNT5A—cervical cancer	5.49e-06	0.00137	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—CA9—cervical cancer	5.04e-06	0.00126	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—CA9—cervical cancer	4.99e-06	0.00125	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—cervical cancer	4.65e-06	0.00116	CbGpPWpGaD
Daunorubicin—YWHAG—Cell Cycle—TP53—cervical cancer	4.24e-06	0.00106	CbGpPWpGaD
Daunorubicin—XDH—Metabolism—MTHFR—cervical cancer	4.2e-06	0.00105	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—CA9—cervical cancer	3.61e-06	0.000902	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—cervical cancer	3.52e-06	0.000879	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—CA9—cervical cancer	3.41e-06	0.000852	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—cervical cancer	3.39e-06	0.000847	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—HES1—cervical cancer	3.16e-06	0.000789	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—MTHFR—cervical cancer	3.09e-06	0.000773	CbGpPWpGaD
Daunorubicin—TOP2A—Cell Cycle—TP53—cervical cancer	2.97e-06	0.000741	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—MTHFR—cervical cancer	2.77e-06	0.000693	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—TERT—cervical cancer	2.77e-06	0.000691	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—CA9—cervical cancer	2.72e-06	0.00068	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—cervical cancer	2.69e-06	0.000671	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—FGFR3—cervical cancer	2.54e-06	0.000634	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—NOTCH1—cervical cancer	2.38e-06	0.000595	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—MTHFR—cervical cancer	2.32e-06	0.00058	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—cervical cancer	2.26e-06	0.000564	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—MTHFR—cervical cancer	2.25e-06	0.000561	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—CA9—cervical cancer	2.17e-06	0.000543	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—MTHFR—cervical cancer	2.04e-06	0.000511	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—MTHFR—cervical cancer	2.02e-06	0.000505	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—MTOR—cervical cancer	1.79e-06	0.000446	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—CD4—cervical cancer	1.78e-06	0.000445	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—CA9—cervical cancer	1.68e-06	0.000419	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—CTNNB1—cervical cancer	1.58e-06	0.000396	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—MTHFR—cervical cancer	1.47e-06	0.000366	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—MTHFR—cervical cancer	1.38e-06	0.000346	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—STAT3—cervical cancer	1.38e-06	0.000345	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—EGFR—cervical cancer	1.25e-06	0.000313	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—MTHFR—cervical cancer	1.11e-06	0.000276	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—MTHFR—cervical cancer	8.83e-07	0.00022	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—MTHFR—cervical cancer	6.81e-07	0.00017	CbGpPWpGaD
